PQ 253
253. Deputy Stephen S. Donnelly asked the Minister for Health the analysis used by the National Centre for Pharmaeconomics in their decision not to make Pirfendione available for patients with Idiopathic Pulmonary Fibrosis on economic grounds; and if he will make a statement on the matter. [23124/13]
Introduced
15 May 2013
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
15 May 2013
Summary
253. Deputy Stephen S. Donnelly asked the Minister for Health the analysis used by the National Centre for Pharmaeconomics in their decision not to make Pirfendione available for patients with Idiopathic Pulmonary Fibrosis on economic grounds; and if he will make a statement on the matter. [23124/13]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products Availability
Medicinal Products Availability
xml · EN · 15 May 2013
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2013-05-15/253/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2013-05-15/pq_253